Daclatasvir/asunaprevir/beclabuvir fixed-dose combination in Japanese patients with HCV genotype 1 infection.
about
Efficacy of Interferon-Free Therapies for Chronic Hepatitis C: A Systematic Review of All Randomized Clinical Trials.Daclatasvir/Asunaprevir/Beclabuvir (DCV-TRIO), All-Oral, Fixed-Dose Combination for Patients With Chronic HCV Genotype 1.Chronic hepatitis caused by hepatitis C virus showing a discrepancy between serogroup and genotype because of intergenotypic 2b/1b recombination: A pitfall in antiviral therapy with direct-acting antivirals.HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients.NS5B polymerase inhibitors in phase II clinical trials for HCV infection.Effects of a Fixed-Dose Co-Formulation of Daclatasvir, Asunaprevir, and Beclabuvir on the Pharmacokinetics of a Cocktail of Cytochrome P450 and Drug Transporter Substrates in Healthy Subjects.Integrated Resistance Analysis of CERTAIN-1 and CERTAIN-2 Studies in Hepatitis C Virus-Infected Patients Receiving Glecaprevir and Pibrentasvir in Japan.Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis C.Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL.
P2860
Q38837174-5D00C5F1-1334-41C9-819B-B466B2CA285AQ38859479-6ADCD271-5488-4BE3-A841-6A97E15AF257Q45327178-7FCE5A9D-4302-4B38-B1EB-8672BE360791Q47138788-2103103B-1951-43BF-A187-0ADCC1AF2E78Q47260158-FEE17623-AD8B-4C43-AA90-299106D788D6Q47278098-945B3A83-27DE-4253-B965-98B7C6A48540Q47572297-6090FAFF-3CA7-4D98-BAC9-C966B67F3D6AQ47593083-2692FA56-6985-4E34-AB44-F2F3173F8BC7Q54223871-27A93BCE-2692-4992-B587-BD414391A252
P2860
Daclatasvir/asunaprevir/beclabuvir fixed-dose combination in Japanese patients with HCV genotype 1 infection.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Daclatasvir/asunaprevir/beclab ...... with HCV genotype 1 infection.
@en
type
label
Daclatasvir/asunaprevir/beclab ...... with HCV genotype 1 infection.
@en
prefLabel
Daclatasvir/asunaprevir/beclab ...... with HCV genotype 1 infection.
@en
P2093
P2860
P1476
Daclatasvir/asunaprevir/beclab ...... with HCV genotype 1 infection.
@en
P2093
Eiichi Tomita
Eugene Scott Swenson
Fiona McPhee
Fumitaka Suzuki
Fusao Ikeda
Hideaki Watanabe
Hiroki Ishikawa
Hiromitsu Kumada
Hitoshi Yoshiji
P2860
P304
P356
10.1007/S00535-016-1245-6
P577
2016-08-09T00:00:00Z